Shigeki Kuroishi
Overview
Explore the profile of Shigeki Kuroishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yasui H, Inui N, Fujisawa T, Karayama M, Enomoto N, Nakamura Y, et al.
Clin Med Insights Circ Respir Pulm Med
. 2018 Jun;
12:1179548418771702.
PMID: 29881320
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia....
2.
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study
Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby T, et al.
Respir Med
. 2017 Nov;
133:1-5.
PMID: 29173442
Background: Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE) requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings are consistent with typical PPFE and when pulmonary apical...
3.
Suzuki Y, Oyama Y, Hozumi H, Imokawa S, Toyoshima M, Yokomura K, et al.
Ann Allergy Asthma Immunol
. 2017 Sep;
119(5):422-428.e2.
PMID: 28942952
Background: Chronic eosinophilic pneumonia (CEP) is characterized by the accumulation of eosinophils in the lung with unknown etiology. Although systemic corticosteroid administration leads to dramatic improvement, nearly half the patients...
4.
Oyama Y, Enomoto N, Suzuki Y, Kono M, Fujisawa T, Inui N, et al.
Respir Med
. 2017 Feb;
123:63-70.
PMID: 28137498
Background: Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial pneumonia with upper lobe predominance and fibroelastosis. Although definite diagnosis requires surgical lung biopsy (SLB), SLB is often difficult because of its...
5.
Mori K, Fujisawa T, Inui N, Hashimoto D, Enomoto N, Nakamura Y, et al.
Respir Med
. 2016 Oct;
119:1-6.
PMID: 27692128
Background: The stepping down of asthma treatment can be considered when asthma symptoms have been well controlled with inhaled corticosteroids (ICSs)/long-acting β2 adrenergic agonists (LABAs). However, few data are available...
6.
Suzuki S, Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, et al.
Invest New Drugs
. 2016 Jun;
34(4):490-6.
PMID: 27279143
Objectives Maintenance therapy is a standard therapeutic strategy in non-squamous non-small-cell lung cancer. However, there is no consensus regarding the benefit of maintenance therapy for patients with squamous cell lung...
7.
Suzuki S, Karayama M, Inui N, Kuroishi S, Fujisawa T, Enomoto N, et al.
Med Oncol
. 2016 May;
33(7):65.
PMID: 27235141
Chemotherapy-induced nausea and vomiting is a challenging issue. Although aprepitant is sometimes used as a therapeutic option in patients receiving moderately emetogenic chemotherapy, the potential benefit of sequential addition of...
8.
Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, et al.
Eur J Cancer
. 2016 Feb;
58:30-7.
PMID: 26922170
Objectives: Single agent maintenance therapy is widely accepted for advanced non-squamous non small cell lung cancer (NSCLC). However, there is no consensus on the initial and maintenance phase regimens, and...
9.
Kusagaya H, Inui N, Karayama M, Fujisawa T, Enomoto N, Kuroishi S, et al.
Lung Cancer
. 2016 Jan;
90(3):410-6.
PMID: 26791800
Objectives: Although antiemetic management has improved, better control of chemotherapy-induced nausea and vomiting (CINV), particularly during the delayed phase, is needed. The benefit of combination therapy using dexamethasone and the...
10.
Urano S, Suzuki Y, Anzawa K, Ohishi T, Kuroishi S, Itoh N, et al.
Med Mycol J
. 2015 Mar;
55(4):J151-6.
PMID: 25742995
In black fungal infections, Exophiala species are frequently encountered as causative agents of human mycosis, particularly in immunocompromised patients. Among them, Exophiala jenselmei was previously reported as the most common...